Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

93
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
93
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

458
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
458
Autoimmune Disorders01:29

Autoimmune Disorders

450
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
450
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

347
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
347

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.

The American journal of gastroenterology·2026
Same author

Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis".

Journal of gastroenterology and hepatology·2026
Same author

Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Hepatology communications·2026
Same author

Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Clover Honey Limits Survival of Enterotoxigenic Escherichia coli in an In Vitro Gastric Model and Reduces In Vitro Fermentation pH of Small Intestine Microbes.

The Journal of nutrition·2026
Same author

Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE.

Liver international : official journal of the International Association for the Study of the Liver·2026

Related Experiment Video

Updated: Jul 11, 2025

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.8K

Autoimmune Markers in Primary Biliary Cholangitis.

Shivani K Shah1, Christopher L Bowlus1

  • 1Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, 4150 V Street, PSSB 3500, Sacramento, CA 95817, USA.

Clinics in Liver Disease
|November 9, 2023
PubMed
Summary

Primary biliary cholangitis (PBC) diagnosis relies on anti-mitochondrial antibodies (AMA). For AMA-negative cases, novel biomarkers and various laboratory methods aid in identifying this chronic cholestatic liver disease.

Keywords:
AMAANAAnti-mitochondrial antibodyAntinuclear antibodyPrimary biliary cholangitisSp100gp210

More Related Videos

Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

6.9K
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.2K

Related Experiment Videos

Last Updated: Jul 11, 2025

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

134.8K
Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

6.9K
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.2K

Area of Science:

  • Hepatology and Immunology
  • Autoimmune Liver Diseases
  • Diagnostic Biomarkers

Background:

  • Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease.
  • Anti-mitochondrial antibody (AMA) is the most common serological marker, found in 90-95% of PBC patients.
  • A subset of PBC patients are AMA-negative, necessitating alternative diagnostic approaches.

Purpose of the Study:

  • To review diagnostic antibodies associated with Primary Biliary Cholangitis (PBC).
  • To discuss laboratory methods for antibody detection in PBC.
  • To highlight novel biomarkers for AMA-negative PBC cases.

Main Methods:

  • Review of established and emerging laboratory techniques for antibody evaluation.
  • Description of immunofluorescence assays.
  • Explanation of enzyme-linked immunosorbent assay (ELISA), immunoblotting, and bead-based assays.

Main Results:

  • Anti-mitochondrial antibody (AMA) is a highly prevalent biomarker in PBC.
  • Novel biomarkers including Sp100, gp210, kelch-like-12, and hexokinase-1 antibodies are valuable for AMA-negative PBC.
  • Multiple laboratory methods exist for detecting these diagnostic antibodies.

Conclusions:

  • Accurate diagnosis of PBC involves identifying specific autoantibodies.
  • A combination of AMA and novel biomarkers improves diagnostic sensitivity, especially in AMA-negative individuals.
  • Various laboratory methods provide reliable means for antibody detection in PBC.